Art

J-GLOBAL ID：201702275461564261   Reference number：17A0136219

Serotonin 5-HT2B receptor antagonism is fundamental for protecting PC12 cells exposed to hydrogen peroxide

セロトニン5-HT2B受容体拮抗作用は過酸化水素に曝露したPC12細胞を保護する基本である

Author (12)： Takayanagi Takeshi (Division of Endocrinology and Metabolism, Department of Internal Medicine, Fujita Health University School of Medicine) ,  Kaneko S. Yoko (Department of Physiology, Fujita Health University School of Medicine) ,  Nagasaki Hiroshi (Department of Physiology, Fujita Health University School of Medicine) ,  Kodani Yu ,  Nakashima Akira ,  Mori Keiji (Department of Health Sciences, Kinjo University) ,  Suzuki Atsushi (Division of Endocrinology and Metabolism, Department of Internal Medicine, Fujita Health University School of Medicine) ,  Itoh Mitsuyasu (Division of Endocrinology and Metabolism, Department of Internal Medicine, Fujita Health University School of Medicine) ,  Kondo Kazunao (Department of Pharmacology, Fujita Health University School of Medicine) ,  Nagatsu Toshiharu (Department of Pharmacology, Fujita Health University School of Medicine) ,  Ota Miyuki (Department of Psychiatry, Tosei General Hospital) ,  Ota Akira (Department of Physiology, Fujita Health University School of Medicine)
Material： Fujita Medical Journal (Web)  (Fujita Med J (Web))
Volume： 1  Issue： 1  Page： 1-5(J-STAGE)  Publication year： 2015 
JST Material Number： U0775A  ISSN： 2189-7255  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： PC12 cell ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0136219&from=J-GLOBAL&jstjournalNo=U0775A") }}

Author keywords (5)： hydrogen peroxide ,  PC12 cells ,  aripiprazole ,  serotonin 5-HT2B-receptor ,  dopamine D1-receptor

JST classification (1)： Basic research of psychotropic drugs  (GW03100Y)

Substance index (1)： Aripiprazole

Reference (36)：

• 1. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 2002;302:381-9.
• 2. Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, Altar CA. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol 2002;441:137-40.
• 3. Keltner NL, Johnson V. Biological perspectives. Aripiprazole: a third generation of antipsychotics begins? Perspect Psychiatr Care 2002;38:157-9.
• 4. Roth BL, Ciaranello RD, Meltzer HY. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J Pharmacol Exp Ther 1992;260:1361-5.
• 5. Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 2003;28:1400-11.

Terms in the title (6)： セロトニン ,  5-HT2B受容体 ,  拮抗作用 ,  過酸化水素 ,  曝露 ,  PC12細胞